1-6 of 6
Austin G. Kulasekararaj
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and associated with high response rates.

Clinical Trials & Observations
Ana Rita BM da Fonseca, Caio Cesar Justino, Vinicius Campos de Molla, Patricia Eiko Yamakawa, Iara Baldim Rabelo, Louise M Arnold, Richard J Kelly, Morag Griffin, Talha Munir, Anita Hill, Elvira D R P Velloso, Thales Dalessandro, Antonio Maria Risitano, Phillip Scheinberg, Austin G Kulasekararaj, Celso Arrais-Rodrigues
Journal: Blood Advances
Blood Adv bloodadvances.2024014159.
https://doi.org/10.1182/bloodadvances.2024014159
Published: 2024
Journal Articles

Consensus recommendations for severe aplastic anemia

Phillip Scheinberg, Austin G. Kulasekararaj
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5719–5720.
https://doi.org/10.1182/bloodadvances.2024013529
Published: 2024
Journal Articles

Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria

Clinical Trials & Observations
Satheesh Chonat, Alexander Kulagin, Alexey Maschan, Marije Bartels, Jochen Buechner, Rowena Punzalan, Michael Richards, Masayo Ogawa, Eden Hicks, Ji Yu, André Baruchel, Austin G. Kulasekararaj
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2813–2824.
https://doi.org/10.1182/bloodadvances.2023012267
Published: 2024
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Matthew Collin, Jakob Passweg, Claude E. Bulabois, Anjum Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G. Kulasekararaj, Patrick J. Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsène Mekinian, Sinisa Savic, Maria Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Tobias Alexander, Marie Robin, Raffaella Greco, Donal P. McLornan
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1444–1448.
https://doi.org/10.1182/bloodadvances.2023012478
Published: 2024
Includes: Supplemental data
Journal Articles

Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

Clinical Trials & Observations
Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric S. Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizua, Richard A. Wells, Jun Ho Jang, Austin G. Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner, Jong Wook Lee
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2176–2185.
https://doi.org/10.1182/bloodadvances.2018020644
Published: 2018
Includes: Supplemental data
Journal Articles

Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms

Judith C. W. Marsh, Fernanda Gutierrez-Rodrigues, James Cooper, Jie Jiang, Shreyans Gandhi, Sachiko Kajigaya, Xingmin Feng, Maria del Pilar F. Ibanez, Flávia S. Donaires, João P. Lopes da Silva, Zejuan Li, Soma Das, Maria Ibanez, Alexander E. Smith, Nicholas Lea, Steven Best, Robin Ireland, Austin G. Kulasekararaj, Donal P. McLornan, Anthony Pagliuca, Isabelle Callebaut, Neal S. Young, Rodrigo T. Calado, Danielle M. Townsley, Ghulam J Mufti
Journal: Blood Advances
Blood Adv (2018) 2 (1): 36–48.
https://doi.org/10.1182/bloodadvances.2017008110
Published: 2018
Includes: Supplemental data